Reunion Neuroscience Inc.

NasdaqGS:REUN Stock Report

Market Cap: US$12.5m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Reunion Neuroscience Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Greg Mayes

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure3.3yrs

Recent management updates

Recent updates

Reunion Neuroscience announces resignation of director, general counsel

Oct 07

Reunion Neuroscience appoints Greg Mayes as President and CEO

Sep 28

Field Trip Health  GAAP EPS of -C$0.09

Aug 15

Field Trip Health receives final court approval for clinics business spin-out

Jun 29

CEO

Greg Mayes (54 yo)

less than a year

Tenure

Mr. Gregory T. Mayes, also known as Greg, Esq., J.D., is President and Chief Executive Officer of Reunion Neuroscience Inc. from September 2022 and serves as its Director since October 07, 2022. He served...

Leadership Team

NamePositionTenureCompensationOwnership
Hannan Fleiman
Co-Founder & Non-Independent Directorno dataCA$282.64k6.11%
$ 762.1k
Nathan Bryson
Chief Science Officer3.3yrsCA$411.37k0.010%
$ 1.2k
Gregory Mayes
Presidentless than a yearno datano data
Edward Smith
Chief Financial Officerless than a yearno datano data
Curtis Weber
General Counselless than a yearno data0.55%
$ 68.8k
Stephan Cote
Head of Quality1.7yrsno data0.0068%
$ 851.6
Robert Alexander
Chief Medical Officer & Senior Advisorless than a yearno datano data

0.9yrs

Average Tenure

53yo

Average Age

Experienced Management: REUN's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Hannan Fleiman
Co-Founder & Non-Independent Director4.3yrsCA$282.64k6.11%
$ 762.1k
Gregory Mayes
Presidentless than a yearno datano data
Robert Alexander
Chief Medical Officer & Senior Advisorno datano datano data
Barry Fishman
Independent Lead Director2.2yrsCA$676.69k0.26%
$ 31.9k
Michael Ehlers
Advisorno datano datano data
Sidney Kennedy
Member of Medical Advisory Boardno datano datano data
Helen Boudreau
Independent Director3.3yrsCA$97.62kno data
Dieter Weinand
Independent Director3.3yrsCA$65.08kno data
Joseph del Moral
Chairman of the Board4.3yrsCA$282.64k9.58%
$ 1.2m
Barry Waisglass
Member of Medical Advisory Boardno datano datano data
John Hanlon
Member of Medical Advisory Boardno datano datano data
Robert McMaster
Member of Medical Advisory Boardno datano datano data

3.3yrs

Average Tenure

54yo

Average Age

Experienced Board: REUN's board of directors are considered experienced (3.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/08/03 18:08
End of Day Share Price 2023/07/31 00:00
Earnings2023/03/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Reunion Neuroscience Inc. is covered by 8 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MartinBloom Burton & Co.
Elemer PirosD. Boral Capital LLC.
Sepehr ManochehryEight Capital